Back
Nurix Therapeutics, Inc. 10K Form
Buy
58
NRIX
Nurix Therapeutics, Inc.
Last Price:
$15.52
Seasonality Move:
9.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NRIX News And Ratings
See the #1 stock for the next 7 days that we like better than NRIX
NRIX Financial Statistics
Sales & Book Value
| Annual Sales: | $84M |
|---|---|
| Cash Flow: | $-73M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.29 |
| Price / Book: | 2.97 |
Profitability
| EPS (TTM): | -3.04210 |
|---|---|
| Net Income (TTM): | $-264.5M |
| Gross Margin: | $65.1M |
| Return on Equity: | -55.88% |
| Return on Assets: | -42.56% |
Nurix Therapeutics, Inc. Earnings Forecast
Key Nurix Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for NRIX is 77.55%.
-
The Selling, General & Administrative Expenses for NRIX have been equal to 62.80% of Gross Profit Margin.
-
The Research & Development expenses have been 366.95% of Revenue.
-
The Net Earning history of NRIX is -314.90% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Nurix Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NRIX |
| CUSIP: | 67080M |
| Website: | nurixtx.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 7.02 |
| Quick Ratio: | 6.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NRIX Technical Analysis vs Fundamental Analysis
Buy
58
Nurix Therapeutics, Inc. (NRIX)
is a Buy
Is Nurix Therapeutics, Inc. a Buy or a Sell?
-
Nurix Therapeutics, Inc. stock is rated a BuyThe current Nurix Therapeutics, Inc. [NRIX] share price is $15.51. The Score for NRIX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.